Variant report
Variant | nsv961743 |
---|---|
Chromosome Location | chr2:187148271-187159618 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:187144221..187146013-chr2:187148146..187151029,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562944942 | chr2:187148283-187148284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191906330 | chr2:187148363-187148364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73035248 | chr2:187148369-187148370 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs140610280 | chr2:187148386-187148387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528384112 | chr2:187148390-187148391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546531260 | chr2:187148409-187148410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544816661 | chr2:187148416-187148417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181964603 | chr2:187148417-187148418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535038214 | chr2:187148420-187148421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145698798 | chr2:187148459-187148460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371823872 | chr2:187148470-187148471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558386249 | chr2:187148493-187148494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539191143 | chr2:187148520-187148521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4130802 | chr2:187148535-187148536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553317824 | chr2:187148545-187148546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4130801 | chr2:187148555-187148556 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs573402116 | chr2:187148576-187148577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539356954 | chr2:187148612-187148613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557660841 | chr2:187148676-187148677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76483655 | chr2:187148686-187148687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs80351628 | chr2:187148688-187148689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146144221 | chr2:187148714-187148715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368652481 | chr2:187148784-187148785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534495130 | chr2:187148798-187148799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539811982 | chr2:187148828-187148829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556051419 | chr2:187148870-187148871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574410127 | chr2:187148874-187148875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544585294 | chr2:187148908-187148909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185736511 | chr2:187148972-187148973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs578033682 | chr2:187149011-187149012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545218994 | chr2:187149021-187149022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111311994 | chr2:187149055-187149056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564297726 | chr2:187149066-187149067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528231980 | chr2:187149103-187149104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6734080 | chr2:187149142-187149143 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs138182088 | chr2:187149228-187149229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529165959 | chr2:187149271-187149272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540618573 | chr2:187149392-187149393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190544070 | chr2:187149403-187149404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370978085 | chr2:187149412-187149413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141846623 | chr2:187149413-187149414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182382805 | chr2:187149426-187149427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150684988 | chr2:187149442-187149443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551225095 | chr2:187149443-187149444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566568097 | chr2:187149510-187149511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186346591 | chr2:187149549-187149550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556014353 | chr2:187149584-187149585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567946855 | chr2:187149593-187149594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555917316 | chr2:187149633-187149634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538567558 | chr2:187149700-187149701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:187147800-187167600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:187152200-187153200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:187152400-187153000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:187159000-187159400 | Enhancers | Psoas Muscle | Psoas |
5 | chr2:187159000-187159600 | Enhancers | Rectal Smooth Muscle | rectum |
6 | chr2:187159000-187159600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
7 | chr2:187159000-187160000 | Enhancers | Left Ventricle | heart |
8 | chr2:187159000-187161400 | Enhancers | Fetal Heart | heart |